ARDX
Ardelyx, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.78
+1.89%Margins
Gross margin
94.0%
EBITDA margin
-5.3%
EBIT margin
-7.9%
Net margin
-12.4%
FCF margin
-4.0%
-37.4%
Return on equity
-9.7%
Return on assets
-8.7%
Return on invested capital
0.83x
Asset turnover
-$17.3M
Cash from operations
$1.09
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026